Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma
Clinical trial NCT03358147 · COMPLETED
Trial details
- NCT number
- NCT03358147
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-13
- Primary completion
- 2019-09-12
- Enrollment
- 1077
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.